Sushil Patel Succeeds Philip Astley-Sparke as CEO of Replimune Group, Inc.
PUBLIC · REPLMar 26, 2024
Position
Chief Strategy Officer
Company
Replimune
Sushil Patel, Ph.D.
WoburnBiotechnologyHealth Care
Description
Replimune Group, Inc. announced changes to its executive leadership team, with Sushil Patel succeeding Philip Astley-Sparke as CEO, while Philip Astley-Sparke transitions to the role of Executive Chairman of the Board of Directors. These changes are designed to support the Company’s preparations for the commercial launch of RP1.
Who to call at Replimune, and when
A new leader at Replimune brings new priorities and often new vendors. The first weeks are when they listen.
An alert the day Replimune raises, hires an executive or expands, scored against what you sell
The decision-makers there, with verified emails
Who you already know at Replimune, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Replimune. With Fundz connected, it knows.
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce★★★★★4.8/5 on G2
Company Information
Company
Replimune
Location
Woburn, Massachusetts, United States
About
Replimune is working to advance the science of oncolytic immunotherapy to improve on existing therapies and help treat more patients with a variety of tumor types. Oncolytic immunotherapy uses viruses that have been modified to selectively replicate in and kill tumors.
Replimunes' goal is to develop powerful therapies to overcome cancer.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Replimune changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
WoburnBiotechnologyHealth Care